Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Columbia University
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Columbia University
ClinicalTrials.gov Identifier:
NCT00583349
First received: December 20, 2007
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)